Inhaler Technique, Critical Errors, and Effective Inspiratory Flow in COPD Patients: A Prospective Study Comparing Patients Over and Under 65 Years of Age.

IF 2 4区 医学 Q3 RESPIRATORY SYSTEM
Abraham Bohadana, Amir Jarjoui, Rona Lujan, Sabri Jaffal, Ariel Rokach, Gabriel Izbicki
{"title":"Inhaler Technique, Critical Errors, and Effective Inspiratory Flow in COPD Patients: A Prospective Study Comparing Patients Over and Under 65 Years of Age.","authors":"Abraham Bohadana, Amir Jarjoui, Rona Lujan, Sabri Jaffal, Ariel Rokach, Gabriel Izbicki","doi":"10.1089/jamp.2025.0002","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Introduction:</i></b> Proper inhaler use is critical to the management of chronic obstructive pulmonary disease (COPD), and age plays a significant role in determining the appropriate device. This study evaluated inhaler technique, critical errors, and peak inspiratory flow (PIF) required to activate the inhaler in elderly patients with COPD. <b><i>Methods:</i></b> A total of 81 patients with COPD, 41 aged ≤65 years and 40 aged >65 years, using at least one pressurized metered-dose inhaler (pMDI), dry powder inhaler (DPI), or soft mist inhaler (SMI) were included in the study. Inhaler technique was assessed using a checklist and critical errors were identified. PIF was measured with the In-Check DIAL device and compared with the optimal reference value for each type of inhaler. <b><i>Results:</i></b> Patients over 65 years of age had lower technique scores (<i>p</i> < 0.001) and a higher incidence of critical errors (<i>p</i> < 0.001) compared with younger patients. Older patients using three inhalers had lower technique scores than those using one or two inhalers (<i>p</i> < 0.001) and had five times more critical errors than younger patients (<i>p</i> < 0.02). A strong correlation between the number of critical errors and technique score was observed in the older group (<i>r</i> = 0.74; <i>p</i> < 0.001). In both groups, critical errors were identified in patients with good or high technical score. With the exception of four older patients, all participants, regardless of age or obstruction severity, achieved the required PIF for proper inhaler activation. <b><i>Conclusion:</i></b> In conclusion, patients over 65 years of age with COPD showed a tendency to misuse inhalers, especially pMDIs and multiple inhalers. Patients with adequate or high technique scores in both age groups made critical errors highlighting the importance of investigating the nature of the error regardless of the technique score. By considering the minimum flow value for each inhaler, almost all patients were able to achieve an effective PIF for inhaler activation.</p>","PeriodicalId":14940,"journal":{"name":"Journal of Aerosol Medicine and Pulmonary Drug Delivery","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Aerosol Medicine and Pulmonary Drug Delivery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/jamp.2025.0002","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Proper inhaler use is critical to the management of chronic obstructive pulmonary disease (COPD), and age plays a significant role in determining the appropriate device. This study evaluated inhaler technique, critical errors, and peak inspiratory flow (PIF) required to activate the inhaler in elderly patients with COPD. Methods: A total of 81 patients with COPD, 41 aged ≤65 years and 40 aged >65 years, using at least one pressurized metered-dose inhaler (pMDI), dry powder inhaler (DPI), or soft mist inhaler (SMI) were included in the study. Inhaler technique was assessed using a checklist and critical errors were identified. PIF was measured with the In-Check DIAL device and compared with the optimal reference value for each type of inhaler. Results: Patients over 65 years of age had lower technique scores (p < 0.001) and a higher incidence of critical errors (p < 0.001) compared with younger patients. Older patients using three inhalers had lower technique scores than those using one or two inhalers (p < 0.001) and had five times more critical errors than younger patients (p < 0.02). A strong correlation between the number of critical errors and technique score was observed in the older group (r = 0.74; p < 0.001). In both groups, critical errors were identified in patients with good or high technical score. With the exception of four older patients, all participants, regardless of age or obstruction severity, achieved the required PIF for proper inhaler activation. Conclusion: In conclusion, patients over 65 years of age with COPD showed a tendency to misuse inhalers, especially pMDIs and multiple inhalers. Patients with adequate or high technique scores in both age groups made critical errors highlighting the importance of investigating the nature of the error regardless of the technique score. By considering the minimum flow value for each inhaler, almost all patients were able to achieve an effective PIF for inhaler activation.

吸入器技术、严重错误和COPD患者的有效吸气流量:一项比较65岁以上和65岁以下患者的前瞻性研究。
正确使用吸入器对慢性阻塞性肺疾病(COPD)的治疗至关重要,年龄在确定合适的吸入器方面起着重要作用。本研究评估了老年COPD患者激活吸入器所需的吸入器技术、临界错误和峰值吸气流量(PIF)。方法:共纳入81例COPD患者,年龄≤65岁41例,年龄≥65岁40例,使用至少一种加压计量吸入器(pMDI)、干粉吸入器(DPI)或软雾吸入器(SMI)。使用检查表对吸入器技术进行评估,并确定了严重错误。使用In-Check DIAL装置测量PIF,并与每种吸入器的最佳参考值进行比较。结果:65岁以上的患者与年轻患者相比,技术评分较低(p < 0.001),严重错误发生率较高(p < 0.001)。使用三个吸入器的老年患者的技术评分低于使用一个或两个吸入器的患者(p < 0.001),严重错误是年轻患者的5倍(p < 0.02)。在老年组中,严重错误次数与技术评分之间存在较强的相关性(r = 0.74;P < 0.001)。在两组中,在技术得分高或好的患者中都发现了严重错误。除4名老年患者外,所有参与者,无论年龄或阻塞严重程度,都达到了适当激活吸入器所需的PIF。结论:65岁以上COPD患者存在滥用吸入器的倾向,尤其是pmdi和多重吸入器。在两个年龄组中,技术得分足够或很高的患者都犯了严重错误,强调了无论技术得分如何,调查错误性质的重要性。通过考虑每个吸入器的最小流量值,几乎所有患者都能够实现吸入器激活的有效PIF。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.70
自引率
2.90%
发文量
34
审稿时长
>12 weeks
期刊介绍: Journal of Aerosol Medicine and Pulmonary Drug Delivery is the only peer-reviewed journal delivering innovative, authoritative coverage of the health effects of inhaled aerosols and delivery of drugs through the pulmonary system. The Journal is a forum for leading experts, addressing novel topics such as aerosolized chemotherapy, aerosolized vaccines, methods to determine toxicities, and delivery of aerosolized drugs in the intubated patient. Journal of Aerosol Medicine and Pulmonary Drug Delivery coverage includes: Pulmonary drug delivery Airway reactivity and asthma treatment Inhalation of particles and gases in the respiratory tract Toxic effects of inhaled agents Aerosols as tools for studying basic physiologic phenomena.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信